The Rare Diseases Foundation has joined forces with SATT Nord to congratulate the creation of the start-up company Hemerion, headed by Dr Maximilien Vermandel. The technologies developed by Hemerion, which are the subject of a transfer, originate from the OncoThAI laboratory (UMR U1189 - Inserm - CHU de Lille - University of Lille).
